[go: up one dir, main page]

IS6980A - 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum - Google Patents

3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum

Info

Publication number
IS6980A
IS6980A IS6980A IS6980A IS6980A IS 6980 A IS6980 A IS 6980A IS 6980 A IS6980 A IS 6980A IS 6980 A IS6980 A IS 6980A IS 6980 A IS6980 A IS 6980A
Authority
IS
Iceland
Prior art keywords
diazabicyclo
preparations
antithrombotic compounds
antithrombotic
compounds
Prior art date
Application number
IS6980A
Other languages
English (en)
Inventor
Barnwell Neil
Björe Annika
Cheema Lal
Cladingboel David
Herring Adam
Lövqvist Karin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6980A publication Critical patent/IS6980A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS6980A 2001-04-12 2003-10-08 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum IS6980A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101327A SE0101327D0 (sv) 2001-04-12 2001-04-12 New crystalline forms
PCT/SE2002/000725 WO2002083688A1 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds

Publications (1)

Publication Number Publication Date
IS6980A true IS6980A (is) 2003-10-08

Family

ID=20283783

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6980A IS6980A (is) 2001-04-12 2003-10-08 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum

Country Status (29)

Country Link
US (1) US7217708B2 (is)
EP (2) EP1389213B1 (is)
JP (1) JP2004525970A (is)
KR (1) KR20030087078A (is)
CN (1) CN1269823C (is)
AR (1) AR035452A1 (is)
AT (1) ATE323095T1 (is)
BR (1) BR0208829A (is)
CA (1) CA2443470A1 (is)
CZ (1) CZ20032760A3 (is)
DE (1) DE60210598T2 (is)
DK (1) DK1389213T3 (is)
EE (1) EE200300504A (is)
ES (1) ES2261721T3 (is)
HU (1) HUP0303487A3 (is)
IL (1) IL158250A0 (is)
IS (1) IS6980A (is)
MX (1) MXPA03009206A (is)
NO (1) NO20034527L (is)
NZ (1) NZ528560A (is)
PL (1) PL367179A1 (is)
PT (1) PT1389213E (is)
RU (1) RU2286993C2 (is)
SE (1) SE0101327D0 (is)
SK (1) SK12572003A3 (is)
TW (1) TWI237025B (is)
UA (1) UA74629C2 (is)
WO (1) WO2002083688A1 (is)
ZA (1) ZA200307759B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI259836B (en) * 2001-04-12 2006-08-11 Astrazeneca Ab Modified release formulation suitable for antiarrhythmic compounds
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
CA2609938A1 (en) * 2005-06-13 2006-12-21 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
AR057363A1 (es) * 2005-06-20 2007-11-28 Astrazeneca Ab Proceso para la preparacion de oxabispidinas n,n'-disustituidas
AR053901A1 (es) * 2005-06-20 2007-05-23 Astrazeneca Ab Formas fisicas de oxabispidinas n,n'- disustituidas
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
WO2007103970A2 (en) * 2006-03-07 2007-09-13 Endacea, Inc. Compositions and methods for treating respiratory disorders
NZ623002A (en) 2006-06-26 2015-08-28 Akebia Therapeutics Inc Prolyl hydroxylase inhibitors and methods of use
NO2686520T3 (is) 2011-06-06 2018-03-17
US20120329836A1 (en) 2011-06-06 2012-12-27 The Ohio State University Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
SI3007695T1 (sl) 2013-06-13 2024-04-30 Akebia Therapeutics, Inc. Sestavki in metode za zdravljenje anemije
PE20160945A1 (es) 2013-11-15 2016-09-26 Akebia Therapeutics Inc Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acetico, composiciones, y usos de las mismas
JP2018502882A (ja) 2015-01-23 2018-02-01 アケビア セラピューティクス インコーポレイテッドAkebia Therapeutics Inc. 2−(5−(3−フルオロフェニル)−3−ヒドロキシピコリンアミド)酢酸の固体形態、その組成物及び使用
HRP20211862T1 (hr) 2015-04-01 2022-03-04 Akebia Therapeutics, Inc. Pripravci za i postupci liječenja anemije
TWI822776B (zh) 2018-05-09 2023-11-21 美商阿克比治療有限公司 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法
CN113631554B (zh) * 2019-03-28 2024-06-21 第一生物治疗股份有限公司 苯并噻唑化合物的药用盐、多晶型物及其制备方法
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9902268D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
HUP0303487A3 (en) 2005-04-28
HUP0303487A2 (hu) 2004-01-28
RU2003129231A (ru) 2005-04-10
SK12572003A3 (sk) 2004-07-07
EP1389213A1 (en) 2004-02-18
TWI237025B (en) 2005-08-01
JP2004525970A (ja) 2004-08-26
WO2002083688A1 (en) 2002-10-24
US20040143000A1 (en) 2004-07-22
US7217708B2 (en) 2007-05-15
EP1389213B1 (en) 2006-04-12
UA74629C2 (en) 2006-01-16
KR20030087078A (ko) 2003-11-12
AR035452A1 (es) 2004-05-26
DE60210598D1 (de) 2006-05-24
CA2443470A1 (en) 2002-10-24
EP1550663A1 (en) 2005-07-06
EE200300504A (et) 2003-12-15
ZA200307759B (en) 2005-01-03
MXPA03009206A (es) 2004-01-29
DK1389213T3 (da) 2006-07-10
NO20034527L (no) 2003-12-10
CZ20032760A3 (cs) 2004-01-14
HK1061026A1 (en) 2004-09-03
PL367179A1 (en) 2005-02-21
BR0208829A (pt) 2004-03-09
CN1269823C (zh) 2006-08-16
CN1514837A (zh) 2004-07-21
RU2286993C2 (ru) 2006-11-10
IL158250A0 (en) 2004-05-12
SE0101327D0 (sv) 2001-04-12
ES2261721T3 (es) 2006-11-16
PT1389213E (pt) 2006-07-31
NZ528560A (en) 2005-05-27
DE60210598T2 (de) 2007-02-08
NO20034527D0 (no) 2003-10-09
ATE323095T1 (de) 2006-04-15

Similar Documents

Publication Publication Date Title
IL160708A0 (en) 1, 6-naphthyridine derivatives as antidiabetics
DE60111734D1 (de) [1,4']-bipiperidin verbindungen
NO20040540L (no) 4-amino-6-fenylpyrrolo[2,3-D]pyrimidinderivater.
ZA200108530B (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents.
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
IS6980A (is) 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
MXPA03009361A (es) Compuestos de urea utilies como agentes anti-inflamatorios.
MXPA03005433A (es) Compuestos de heterociclilalquilindol o-azaindol como ligandos de 5-hidroxitriptamina-6.
AU2003281694A1 (en) 6,11-4-carbon bridged ketolides
PT1210349E (pt) Pirazolo-¬4,3-d|-pirimidinas
ZA200203799B (en) Antithrombotic compound.
ZA200206779B (en) Solid formulation.
IS6989A (is) 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum
IS6990A (is) 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum
GB0130553D0 (en) 1,4-Dihydro-1,4-diphenylpyridine derivitives
MXPA03001263A (es) Formulacion fungicida.
MXPA03000664A (es) Derivados n-sustituidos del acido 1-amino-1, 1-dialquilcarboxilico.
AU6390001A (en) 6,10-dimethyl-5,9-undecadien-2-ol
AU2002361027A1 (en) Substituted 1,5-diaminopentan-3-ol compounds
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
SI1389213T1 (sl) 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine
PL352760A1 (en) Oxathiepino[6,5-b
EG23305A (en) Preparation of 1,2-dicloroethane.
AU2001288637A1 (en) 1,2-oxazin-3-one derivatives as antibacterial agents